Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Yajne on Nov 23, 2022 2:43pm

Volume

Just over 350K on all Cdn exchanges with 1-1/2 hr to mkt close. Reasonable volume on 'no news' ..yet

V:TLT - Theralase Technologies Inc. - https://www.theralase.com
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
TLT - V   200.5 0.305 · 0.31 35.0 0.305 +0.025 8.9 355.1 104 108 0.285  0.32  0.28 0.48  0.21 14:02:59 Nov 22 15 min RT 2¢
TSX-V - V 200.5 0.305 · 0.31 35.0 0.31 +0.03 10.7 175.8 52 43 0.285  0.315  0.285 0.48  0.21 13:50:21   15 min 
NEO ATS - U   0.31 +0.03 10.7 25.5 8 10 0.30  0.315  0.30   13:34:26   15 min 
Alpha - A   0.31 +0.03 10.7 80.0 24 13 0.28  0.315  0.28   13:21:03   15 min 
Omega - O   0.31 +0.03 10.7 24.0 7 7 0.30  0.32  0.30   11:53:20   15 min 
Pure - P   0.28     0.8   4        Aug 26   15 min 
Chi-X - X   0.31 +0.03 10.7 7.0 2 2 0.315  0.315  0.31   13:34:26   15 min 
CX2 - H   0.305 +0.025 8.9 41.0 12 22 0.30  0.315  0.30   14:02:59   15 min 
CXD - D   0.28     0.3 0 1        Sep 12   15 min 
TriAct - M   0.28     0.7 0 6            15 min
Comment by Longholder99 on Nov 23, 2022 3:12pm
Spec buying on pretty decent likelihood of BTD.  Saw one day volume after IBRX achieved BTD of 54M shares in one day.  That's when we know we are rocking. Our day is coming. IMO
Comment by Oilminerdeluxe on Nov 23, 2022 3:18pm
Next week perhaps?
Comment by stocksnbonds458 on Nov 23, 2022 3:25pm
Aren't we putting the BTD cart before the horse? I was under the impression we apply (officially) for BTD in December, then with the grace of God get said designation first quarter 2023.
Comment by robertshaw on Nov 23, 2022 4:10pm
Hope before Chrismas. 
Comment by Eoganacht on Nov 23, 2022 4:26pm
Right. Patient 25 should reach 450 days sometime between Thursday, Nov. 24, 2022 and Saturday, Dec. 24 2022 depending on when in September 2021 he/she was first treated. According to the last MD&A:   "The Company will compile a clinical data report for submission to the FDA in support of the grant of a BTD approval after completion of the 450 day assessments for 25 patients ...more  
Comment by ScienceFirst on Nov 23, 2022 4:31pm
Stockbonds458 ... You have it right.  FGPStuck must have confused some by not being up to date. Application is once p#25 hsa reached 450-days (by mid-December) and that TLT has all the exams, Granting decision by the FDA is 60 days once they received the application.  So probably around early March, more or less. ImmunityBio has been granted simlilar Breakthrough designation on interim ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250